Home Page - 2026 Rare Hematology Conference, Atlanta

The 2026 Rare Hematology Conference in Atlanta is a CME-accredited medical education program designed to improve clinician competence in the diagnosis, evaluation, and management of rare classical (benign) and malignant hematologic disorders. This conference addresses persistent clinical gaps in recognizing uncommon blood diseases, interpreting advanced diagnostics, and applying evolving treatment strategies.

This rare hematology CME conference will feature a balanced curriculum of expert-led didactic lectures and interactive case-based discussions, enabling participants to translate the latest scientific evidence into real-world clinical practice. Topics will include rare anemias, bone marrow failure syndromes, hemoglobinopathies, thrombotic disorders, and rare hematologic malignancies, with a focus on precision medicine, molecular diagnostics, and targeted therapies.

Participants will engage with leading experts in hematology to review current clinical guidelines, emerging therapies, and recent clinical trial data. Case-based sessions will emphasize clinical decision-making, multidisciplinary care, and management of complex or refractory cases, helping clinicians improve patient outcomes in rare and challenging conditions.

This activity is planned and implemented in accordance with Accreditation Council for Continuing Medical Education (ACCME) standards to ensure content is evidence-based, independent, and free from commercial bias. All relevant financial relationships will be disclosed and appropriately mitigated prior to the activity.

Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.

As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses.

As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.

We invite companies interested in improving equitable access to cancer care to support our efforts.

Hyatt Regency Atlanta